KORU Medical Systems, Inc. (NASDAQ:KRMD) Shares Sold by Albion Financial Group UT

Albion Financial Group UT cut its holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 3.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 768,854 shares of the company’s stock after selling 23,855 shares during the period. Albion Financial Group UT owned about 1.68% of KORU Medical Systems worth $1,888,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Advisor Group Holdings Inc. acquired a new stake in KORU Medical Systems during the 1st quarter valued at $64,000. First Light Asset Management LLC lifted its position in shares of KORU Medical Systems by 10.6% in the first quarter. First Light Asset Management LLC now owns 6,099,820 shares of the company’s stock valued at $17,445,000 after acquiring an additional 585,714 shares in the last quarter. Charles Schwab Investment Management Inc. acquired a new stake in shares of KORU Medical Systems during the first quarter valued at $62,000. Meros Investment Management LP increased its position in KORU Medical Systems by 7.7% during the 1st quarter. Meros Investment Management LP now owns 294,286 shares of the company’s stock worth $841,000 after purchasing an additional 21,157 shares in the last quarter. Finally, State Street Corp raised its stake in KORU Medical Systems by 9.2% in the 1st quarter. State Street Corp now owns 114,690 shares of the company’s stock valued at $328,000 after purchasing an additional 9,638 shares during the last quarter. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Trading Down 5.9 %

KRMD traded down $0.15 on Tuesday, reaching $2.32. 66,062 shares of the company’s stock were exchanged, compared to its average volume of 97,133. The company has a market cap of $106.05 million, a price-to-earnings ratio of -8.62 and a beta of 0.53. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.77 and a current ratio of 4.55. KORU Medical Systems, Inc. has a twelve month low of $1.98 and a twelve month high of $4.48. The company’s 50 day moving average is $2.18 and its 200-day moving average is $2.30.

KORU Medical Systems (NASDAQ:KRMD) last announced its quarterly earnings results on Wednesday, March 13th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. The firm had revenue of $7.19 million during the quarter, compared to analysts’ expectations of $7.01 million. Equities analysts predict that KORU Medical Systems, Inc. will post -0.15 earnings per share for the current year.

Analyst Ratings Changes

Separately, B. Riley restated a “buy” rating and set a $4.00 target price on shares of KORU Medical Systems in a research report on Thursday, March 14th.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.